French RegTech startup Cleo Labs has raised €1.5 million in funding to accelerate the development of its AI-powered platform for international product regulatory compliance and to support its expansion across Europe and into the United States.
- Founded in 2024 by Naomie Halioua and Anaëlle Guez, Cleo Labs is building an AI-driven regulatory intelligence system designed to help businesses navigate the complexity of global product regulations. Its platform continuously maps and monitors requirements across more than 25,000 regulatory authorities in 106 countries.
- At the core of the system is MARIA, a multi-agent AI architecture that analyses regulatory texts, tracks updates in real time, and combines automated processing with expert legal validation. The tool generates pre-launch compliance checklists and provides ongoing alerts on regulatory changes, helping companies manage obligations across different markets.
- According to the founders, many teams still rely on manual processes and fragmented tools such as spreadsheets to manage compliance, which slows down product launches and increases operational risk.
"Our ambition is to transform regulatory compliance, currently seen as a constraint, into a strategic lever for companies. Thanks to AI, it becomes possible to anticipate rather than react," explains Naomie Halioua, co-founder of Cleo Labs.
- The platform is already used by companies such as Decathlon and is designed to support organisations launching physical products internationally, where a single product can be subject to hundreds of regulatory requirements across jurisdictions.
Details of the deal
- The financing was backed by Larry Berger, Kima Ventures, Financière Saint-James, and Accel, alongside several business angels including Boris Paillard, Ambre Soubiran, Stéphanie Zolesio, and Charles Sutton.
- The €1.5 million round will be used to further develop the technology, expand coverage to additional markets and product categories, grow the company’s enterprise customer base, and enhance the capabilities of the MARIA system, particularly in real-time monitoring and regulatory validation.
